Human Immunodeficiency Virus
326
23
34
238
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
93 trials with published results (29%)
Research Maturity
238 completed trials (73% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.1%
20 terminated out of 326 trials
92.2%
+5.7% vs benchmark
18%
59 trials in Phase 3/4
39%
93 of 238 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 238 completed trials
Clinical Trials (326)
Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
Cefixime Clinical Trial
Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men
Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM)
Harm Reduction in HIV Primary Care for PLWH Who Use Drugs
Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
Low Dose Naltrexone for Pain in Patients With HIV
Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)
Baricitinib for Reduction of HIV - CNS
ICVAX as a HIV Therapeutic DNA Vaccine
Support for Adolescents Living With HIV in South Africa
Combined Injectable Treatment for HIV and OUD
Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Universal Test and Connect for HIV Service Delivery in South Africa